ibi351,cetuximab,GFH925
innovent biologics,Zhejiang genfleet therapeutics,eli lilly
['rectal', 'colorectal', 'ibi351', '$ivbxf', 'innovent']
$ivbxf new article : innovent presents phase 1 clinical data of ibi351 (krasg12c inhibitor) as monotherapy for metastatic colorectal cancer at the 2023 asco annual meeting 
Effortlessly track financial news and never miss an article again with https://t.co/hKE5DiO0B4. Our real-time database combines trusted financial news sources for easy access.